Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 164.7 USD 0.26% Market Closed
Market Cap: 74.3B USD
Have any thoughts about
Zoetis Inc?
Write Note

Zoetis Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zoetis Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Other Current Assets
$745m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
9%
Johnson & Johnson
NYSE:JNJ
Other Current Assets
$4.2B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Current Assets
$1.8B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-2%
Pfizer Inc
NYSE:PFE
Other Current Assets
$4.2B
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Other Current Assets
$7.4B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Other Current Assets
$8.4B
CAGR 3-Years
40%
CAGR 5-Years
29%
CAGR 10-Years
26%
No Stocks Found

Zoetis Inc
Glance View

Market Cap
74.4B USD
Industry
Pharmaceuticals
Economic Moat
None

In the vast panorama of the global animal health industry, Zoetis Inc. emerges as a formidable player, intricately weaving a narrative of innovation and growth. Originally part of Pfizer, Zoetis embarked on its solo journey in 2013, driven by a singular mission to understand, anticipate, and amplify the needs of both livestock and companion animals. At the heart of its operations lies an impressive pipeline of products—from vaccines and diagnostics to genetic tests and precision livestock farming software—designed to improve the health of animals. Its comprehensive approach ensures not only the well-being of the animals but also supports the burgeoning needs of veterinary practitioners and livestock producers worldwide. Financially, Zoetis masters the art of monetizing its deep-rooted expertise in animal biology and science. Revenue streams flow predominantly from the sale of these innovative products, with livestock and companion animal segments each contributing significant streams of income. The company capitalizes on its extensive global footprint, reaching customers in over 100 countries, ensuring diversified and steady cash flows. Its continued investment in R&D underscores a long-term commitment to innovation, enhancing its product offerings and driving future growth. In a world increasingly conscious of the importance of animal welfare and food security, Zoetis stands at a strategic intersection, aligning its business model with the evolving dynamics of both consumer preferences and regulatory landscapes.

ZTS Intrinsic Value
119.94 USD
Overvaluation 27%
Intrinsic Value
Price

See Also

What is Zoetis Inc's Other Current Assets?
Other Current Assets
745m USD

Based on the financial report for Sep 30, 2024, Zoetis Inc's Other Current Assets amounts to 745m USD.

What is Zoetis Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
9%

Over the last year, the Other Current Assets growth was 59%. The average annual Other Current Assets growth rates for Zoetis Inc have been 25% over the past three years , 18% over the past five years , and 9% over the past ten years .

Back to Top